Randall Kaye Insider Trading $AVNR AVANIR PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Randall Kaye.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Randall Kaye. Randall Kaye is Chief Medical Officer in AVANIR PHARMACEUTICALS, INC. ($AVNR) and Sr. VP, Chief Medical Officer in AVANIR PHARMACEUTICALS, INC. ($AVNR).
Randall Kaye in AVANIR PHARMACEUTICALS, INC.
Trading Symbol: AVNRIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Randall Kaye: Sr. VP, Chief Medical Officer, Chief Medical Officer
Holdings: 165,690 shares
Latest Transaction: Jan 07 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Randall Kaye in AVANIR PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 07 2011 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Sell | S | 4.05 | 10,000 | 40,500 | 165,690 | 175.7 K to 165.7 K (-5.69 %) |
Dec 15 2010 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Payment of Exercise | F | 3.92 | 1,446 | 5,668 | 175,690 | 177.1 K to 175.7 K (-0.82 %) |
Dec 08 2010 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Sell | S | 3.80 | 10,000 | 38,000 | 177,136 | 187.1 K to 177.1 K (-5.34 %) |
Dec 03 2010 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Option Exercise | A | 4.18 | 100,000 | 418,000 | 100,000 | |
Dec 03 2010 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Grant | A | 0.00 | 17,500 | 0 | 196,836 | 179.3 K to 196.8 K (+9.76 %) |
Nov 08 2010 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Sell | S | 4.76 | 10,000 | 47,556 | 187,136 | 197.1 K to 187.1 K (-5.07 %) |
Oct 05 2010 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Sell | S | 3.23 | 10,000 | 32,269 | 227,036 | 237 K to 227 K (-4.22 %) |
Sep 15 2010 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Payment of Exercise | F | 2.70 | 1,447 | 3,907 | 237,036 | 238.5 K to 237 K (-0.61 %) |
Sep 08 2010 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Sell | S | 2.70 | 10,000 | 27,034 | 238,483 | 248.5 K to 238.5 K (-4.02 %) |
Aug 20 2010 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Sell | S | 3.08 | 35,000 | 107,664 | 248,483 | 283.5 K to 248.5 K (-12.35 %) |
Aug 09 2010 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Sell | S | 3.28 | 10,000 | 32,800 | 283,483 | 293.5 K to 283.5 K (-3.41 %) |
Jul 09 2010 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Sell | S | 3.02 | 10,000 | 30,203 | 293,483 | 303.5 K to 293.5 K (-3.30 %) |
Jun 15 2010 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Payment of Exercise | F | 2.71 | 1,447 | 3,921 | 303,483 | 304.9 K to 303.5 K (-0.47 %) |
Jun 08 2010 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Sell | S | 2.38 | 50,000 | 119,115 | 304,930 | 354.9 K to 304.9 K (-14.09 %) |
Mar 16 2010 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Payment of Exercise | F | 2.13 | 1,448 | 3,084 | 354,930 | 356.4 K to 354.9 K (-0.41 %) |
Jan 05 2010 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Payment of Exercise | F | 1.97 | 28,499 | 56,143 | 368,458 | 397 K to 368.5 K (-7.18 %) |
Dec 15 2009 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Payment of Exercise | F | 1.82 | 1,350 | 2,457 | 396,957 | 398.3 K to 397 K (-0.34 %) |
Nov 30 2009 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Option Exercise | A | 1.74 | 210,900 | 366,966 | 210,900 | |
Sep 15 2009 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Sell | S | 2.10 | 2,000 | 4,200 | 398,307 | 400.3 K to 398.3 K (-0.50 %) |
Sep 15 2009 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Payment of Exercise | F | 2.21 | 1,349 | 2,981 | 400,307 | 401.7 K to 400.3 K (-0.34 %) |
Sep 15 2009 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Buy | P | 2.18 | 2,000 | 4,360 | 401,656 | 399.7 K to 401.7 K (+0.50 %) |
Jul 17 2009 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Payment of Exercise | F | 2.13 | 23,425 | 49,895 | 399,656 | 423.1 K to 399.7 K (-5.54 %) |
Jun 15 2009 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Payment of Exercise | F | 1.31 | 1,217 | 1,594 | 423,081 | 424.3 K to 423.1 K (-0.29 %) |
Mar 17 2009 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Payment of Exercise | F | 0.45 | 1,440 | 648 | 424,298 | 425.7 K to 424.3 K (-0.34 %) |
Feb 25 2009 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Buy | P | 0.43 | 5,000 | 2,133 | 425,738 | 420.7 K to 425.7 K (+1.19 %) |
Feb 25 2009 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Buy | P | 0.43 | 5,000 | 2,130 | 420,738 | 415.7 K to 420.7 K (+1.20 %) |
Dec 18 2008 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Option Exercise | A | 0.53 | 185,000 | 98,050 | 185,000 | |
Sep 17 2008 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Sr. VP, Chief Medic ... | Payment of Exercise | F | 0.83 | 1,217 | 1,010 | 415,738 | 417 K to 415.7 K (-0.29 %) |
Jun 16 2008 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Chief Medical Offic ... | Payment of Exercise | F | 1.11 | 1,217 | 1,351 | 416,955 | 418.2 K to 417 K (-0.29 %) |
Mar 17 2008 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Chief Medical Offic ... | Payment of Exercise | F | 1.10 | 1,440 | 1,584 | 418,172 | 419.6 K to 418.2 K (-0.34 %) |
Jan 22 2008 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Chief Medical Offic ... | Option Exercise | M | 0.04 | 12,500 | 500 | 0 | |
Jan 22 2008 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Chief Medical Offic ... | Payment of Exercise | F | 1.13 | 4,983 | 5,631 | 419,612 | 424.6 K to 419.6 K (-1.17 %) |
Jan 22 2008 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Chief Medical Offic ... | Buy | M | 0.04 | 12,500 | 500 | 424,595 | 412.1 K to 424.6 K (+3.03 %) |
Dec 17 2007 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Chief Medical Offic ... | Payment of Exercise | F | 1.66 | 5,148 | 8,546 | 412,095 | 417.2 K to 412.1 K (-1.23 %) |
Dec 06 2007 | AVNR | AVANIR PHARMACEUTI ... | Kaye Randall | Chief Medical Offic ... | Grant | A | 0.00 | 107,143 | 0 | 417,243 | 310.1 K to 417.2 K (+34.55 %) |
Page: 1